NCT00746785View on ClinicalTrials.gov

A New Pharmacotherapy for Alcohol Dependence: Olanzapine

PHASE3CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

May 31, 2010

Study Completion Date

September 30, 2011

Conditions
Alcohol Dependence
Interventions
DRUG

2.5 mg Olanzapine

2.5 mg

DRUG

5mg Olanzapine

5 mg

DRUG

placebo

placebo

Trial Locations (1)

87131

The Mind Research Network, Albuquerque

All Listed Sponsors
lead

The Mind Research Network

OTHER

NCT00746785 - A New Pharmacotherapy for Alcohol Dependence: Olanzapine | Biotech Hunter | Biotech Hunter